2016
DOI: 10.5582/bst.2016.01072
|View full text |Cite
|
Sign up to set email alerts
|

The interconnected role of chemokines and estrogen in bone metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 14 publications
(9 citation statements)
references
References 107 publications
0
9
0
Order By: Relevance
“…In addition, tumor cells secrete many chemoattractants that promote the migratory activity of MSCs and MSCs express receptors of the four chemokine subfamilies: CC, CXC, CX(3)C and C [49]. It should be born in mind that several chemotaxis assays in vitro have shown that Dose-dependent migration of MSCs could be induced by chemokines like CCL2/MCP1 (monocyte chemoattractant protein-1), CCL25 (thymus expressed chemokine), CXCL8 (IL8), CXCL12/SDF1α and CXCL13 (BCA1) [50]. In addition, sphingosine 1 phosphate (S1P) exerted a strong chemoattraction on MSCs through matrix metalloproteinase (MMP)-mediated signaling events and the RhoA/ROCK and MEK1/ERK intracellular pathways [51].…”
Section: Recruitment Of Mscsmentioning
confidence: 99%
“…In addition, tumor cells secrete many chemoattractants that promote the migratory activity of MSCs and MSCs express receptors of the four chemokine subfamilies: CC, CXC, CX(3)C and C [49]. It should be born in mind that several chemotaxis assays in vitro have shown that Dose-dependent migration of MSCs could be induced by chemokines like CCL2/MCP1 (monocyte chemoattractant protein-1), CCL25 (thymus expressed chemokine), CXCL8 (IL8), CXCL12/SDF1α and CXCL13 (BCA1) [50]. In addition, sphingosine 1 phosphate (S1P) exerted a strong chemoattraction on MSCs through matrix metalloproteinase (MMP)-mediated signaling events and the RhoA/ROCK and MEK1/ERK intracellular pathways [51].…”
Section: Recruitment Of Mscsmentioning
confidence: 99%
“…Prevention of bone remodeling by estrogens is a result of osteoclastogenesis prevention from marrow precursors, as well as of induction of the Fas/FasL system that enhances osteoclast apoptosis [ 44 , 45 ]. Estrogens lead to a further inhibition in bone resorption through effects on the receptor activator of nuclear factor-Kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system and the production of some pro-resorptive cytokines (e.g., IL-1, IL-6, IL-7, TNF) [ 46 52 ]. Moreover, estrogens directly affect osteoblastic cells contributing to bone preservation [ 53 , 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…Estradiol stimulates the production of some pro-resorptive cytokines, like interleukins-1, -6, -7 and the tumour necrosis factor [ 52 58 ]. Especially serum interleukin-1β and -6, have been shown to play a principal role in bone resorption [ 59 , 60 ] and to fluctuate during the menstrual cycle in humans [ 61 , 62 ].…”
Section: Discussionmentioning
confidence: 99%